VRTN
Basic information
Region (hg38): 14:74303069-74360008
Previous symbols: [ "C14orf115" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VRTN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 2 | 2 |
Variants in VRTN
This is a list of pathogenic ClinVar variants found in the VRTN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-74303138-C-T | Benign (Jun 29, 2018) | |||
14-74303196-T-A | Likely benign (Mar 17, 2021) | |||
14-74303274-G-A | Benign (Jul 07, 2018) | |||
14-74356826-C-A | not specified | Uncertain significance (Feb 12, 2024) | ||
14-74357336-C-T | not specified | Uncertain significance (Nov 06, 2023) | ||
14-74357337-G-A | not specified | Uncertain significance (Mar 22, 2023) | ||
14-74357363-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
14-74357423-G-A | not specified | Likely benign (Feb 03, 2023) | ||
14-74357496-C-T | not specified | Uncertain significance (May 20, 2024) | ||
14-74357601-T-C | not specified | Uncertain significance (May 11, 2022) | ||
14-74357610-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
14-74357639-T-G | not specified | Uncertain significance (Aug 22, 2023) | ||
14-74357675-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
14-74357708-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
14-74357714-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
14-74357724-T-C | not specified | Uncertain significance (Apr 17, 2023) | ||
14-74357760-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
14-74357767-C-T | Benign (Nov 15, 2017) | |||
14-74357768-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
14-74357794-G-C | not specified | Uncertain significance (Feb 02, 2022) | ||
14-74357795-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
14-74357814-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
14-74357856-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
14-74357961-C-T | not specified | Uncertain significance (Nov 23, 2021) | ||
14-74357994-G-A | not specified | Uncertain significance (Mar 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VRTN | protein_coding | protein_coding | ENST00000256362 | 1 | 56940 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0110 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.67 | 348 | 448 | 0.778 | 0.0000300 | 4478 |
Missense in Polyphen | 103 | 186.89 | 0.55112 | 1839 | ||
Synonymous | 0.813 | 174 | 188 | 0.925 | 0.0000114 | 1547 |
Loss of Function | 3.71 | 1 | 18.0 | 0.0556 | 7.71e-7 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000443 | 0.0000439 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Intolerance Scores
- loftool
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.54
Haploinsufficiency Scores
- pHI
- 0.654
- hipred
- Y
- hipred_score
- 0.626
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vrtn
- Phenotype
- growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- vrtn
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- transposition, DNA-mediated
- Cellular component
- Molecular function
- transposase activity;sequence-specific DNA binding